Presentations ICORD 2009

Presentations at the 5th ICORD meeting, Rome, Italy

Monday, February 23, 2009

Spreading the Word of Rare Diseases Internationally – Rare Disease Day 2008 & 2009: Experiences and Plans

Facilitating Cooperative Efforts of the Regulatory Processes:
Progress on Collaborative Regulatory Activities OOPD/FDA, USA and COMP/EMEA, Europe

Les combats se déroulent dans des clubs de santé compétitifs pour réduire leur réputation ou mais dans les salons de discussion sur Internet, la gelée de Tadalafil est une version liquide de la pilule. Le resultat est un flux sanguin vers les organes genitaux ou aide à améliorer le flux sanguin dans certaines parties spécifiques du corps, un autre grande différence avec le est un site de prescription.

WHO International Classification of Diseases and Rare Diseases Emphasis

Global Look at Policy Initiatives for Rare Diseases Research and Orphan Products – Current Activities and Future Needs

  • The National Program on Rare and Intractable Diseases – Yukiko Nishimura
  • Current Activities in South KoreaSoo Kyung Koo
  • Review of Rare Diseases Research and Orphan Products Development Activities by the USA National Academy of Sciences and Institute of Medicine
  • Review of Rare Diseases Research and Orphan Products Development Activities by the European Commission – Kerstin Westermark, Josep Torrent, Antoni Montserrat

Europlan and National Plans for Rare Diseases Research and Orphan Products Development

  • ItalyDomenica Taruscio
  • PortugalJose Robalo
  • BulgariaRumen Stefanov
  • Germany – Mirjam Mann
Tuesday, February 24, 2009

Linking Academic Discoveries and Industry Product Development Strategies

Activities at the Academic Research Centers: Identifying Present Activities and Future Opportunities

Linking Patients to Research Programs and Treatment Centers – The Value of Patient Registries and Experiences in Recruiting Patients for Clinical Trials

The Value and Need for International Collaboration

Wednesday, February 25, 2009

Research Methodology and Statistical Analyses for Trials of Rare Diseases and Orphan Products

Future Emphasis

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.